Synverdis

Synverdis is a biotechnology company based in Heidelberg, Germany, that develops innovative delivery solutions for nucleic acid-based therapeutics. The company's core technology is the Synthetic Viral Envelope (SVE) platform, which utilizes chemically defined components to mimic the highly efficient entry mechanisms of natural viruses. This approach aims to provide the high delivery efficiency of viral vectors while maintaining the safety, low immunogenicity, and manufacturing advantages of synthetic systems like lipid nanoparticles. Synverdis focuses on enabling targeted delivery of mRNA, siRNA, and gene editing tools to specific tissues that are currently difficult to reach. The company is a spin-off from Heidelberg University Hospital and is positioned to partner with pharmaceutical companies to enhance their genomic medicine pipelines.